Literature DB >> 6201587

Suppressor T cell growth and differentiation. Identification of a cofactor required for suppressor T cell function and distinct from interleukin 2.

S Rich, M R Carpino, C Arhelger.   

Abstract

This report describes a Ts costimulator assay and its use to analyze cofactors required for the expression of suppressor T cell function. Activation of primed MLR-Ts (alloantigen-activated suppressor T cells suppressive of mixed leukocyte reaction) to suppressor T cell factor (TsF) production typically fails in the presence of glutaraldehyde-fixed rather than irradiated allogeneic stimulator cells. However, MLR-TsF production was restored by the addition of 48-h primary MLR supernates; MLR-derived Ts costimulator neither activated primed MLR-Ts in the absence of fixed allogeneic stimulators nor directly suppressed assay MLR. Lack of antigen specificity or genetic restriction and failure to activate unprimed MLR-Ts precursors suggested that Ts costimulator activity differed from previously described Ts inducer functions and was more closely aligned with the lymphocyte- or monocyte-derived interleukins (IL). Three findings distinguished Ts costimulator from IL-2. Depletion of IL-2 activity from MLR supernates by HT2 adsorption failed to affect Ts costimulator function. In addition, MLR supernates prepared in the presence of cyclosporin A contained no IL-2 but expressed Ts costimulator activity. Finally, gel chromatography demonstrated Ts costimulator in peaks of 21,000 and 43,000 mol wt that were largely distinct from the IL-2-containing fractions. Ts costimulator activity was also identified in phorbol myristate acetate (PMA)-induced EL4 supernates and was retained in those supernates after IL-2 depletion by HT2 adsorption. In preliminary functional characterization, MLR supernate-derived Ts costimulator triggered MLR-TsF production from irradiated MLR-Ts in the absence of proliferation. Thus a differentiative rather than proliferative stimulus required for primed MLR-Ts function appears to be provided by this Ts costimulator and has been provisionally termed Ts differentiative factor ( TsDF ). This initial characterization may thus identify one of a possibly distinctive family of interleukins required in the alloantigen-driven activation of suppressor T cells to effector function.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6201587      PMCID: PMC2187293          DOI: 10.1084/jem.159.5.1473

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  48 in total

1.  The separation of different cell classes from lymphoid organs. IX. A simple and rapid method for removal of damaged cells from lymphoid cell suspensions.

Authors:  H von Boehmer; K Shortman
Journal:  J Immunol Methods       Date:  1973-04       Impact factor: 2.303

2.  Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process.

Authors:  E L Larsson
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

3.  Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR.

Authors:  A D Hess; P J Tutschka
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

Review 4.  T-cell growth factor.

Authors:  K A Smith
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

Review 5.  Clones of killer and helper T cells: growth requirements, specificity and retention of function in long-term culture.

Authors:  M H Schreier; N N Iscove; R Tees; L Aarden; H von Boehmer
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

6.  Hapten-specific T-cell responses to 4-hydroxy-3-nitrophenyl acetyl. II. Demonstration of idiotypic determinants on suppressor T cells.

Authors:  J Z Weinberger; R N Germain; S T Ju; M I Greene; B Benacerraf; M E Dorf
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

7.  Regulatory mechanisms in cell-mediated immune responses. VIII. Differential expression of I-region determinants by suppressor cells and their targets in suppression of mixed leukocyte reactions.

Authors:  S S Rich; C S David
Journal:  J Exp Med       Date:  1979-11-01       Impact factor: 14.307

8.  Antigen- and receptor-driven regulatory mechanisms. IV. Idiotype-bearing I-J+ suppressor T cell factors induce second-order suppressor T cells which express anti-idiotypic receptors.

Authors:  M S Sy; M H Dietz; R N Germain; B Benacerraf; M I Greene
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

9.  Continuous proliferation of murine antigen-specific helper T lymphocytes in culture.

Authors:  J Watson
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

10.  Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. V. Role of idiotypes in the suppressor pathway.

Authors:  J Z Weinberger; R N Germain; B Benacerraf; M E Dorf
Journal:  J Exp Med       Date:  1980-07-01       Impact factor: 14.307

View more
  6 in total

1.  Mechanism of MHC class II restriction in the interaction between specific suppressor and responder T cells in a proliferative response: Ia interaction with a putative anti-self receptor, expressed on pre-activated responder cells.

Authors:  M B Zaitseva; B D Brondz
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

Review 2.  Immune suppression genes.

Authors:  D B Oliveira; N A Mitchison
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

Review 3.  The influence of cyclosporin A on cell-mediated immunity.

Authors:  A W Thomson; L M Webster
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

4.  Lymphokine-activated suppressor (LAS) cells in patients with gastric carcinoma.

Authors:  T Ebihara; S Koyama; K Fukao; T Osuga
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

5.  Effect of murine interferon alpha/beta on tumour-induced suppressor function.

Authors:  D M Sahasrabudhe; J C Dusel
Journal:  Cancer Immunol Immunother       Date:  1994-12       Impact factor: 6.968

6.  Differential activation of lymphokine-activated killer cells with different surface phenotypes by cultivation with recombinant interleukin 2 or T-cell growth factor in gastric cancer patients.

Authors:  S Koyama; T Ebihara; K Fukao; T Osuga
Journal:  Jpn J Cancer Res       Date:  1989-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.